A Key Role for Matrix Metalloproteinases and Neutral Sphingomyelinase-2 in Transplant Vasculopathy Triggered by Anti-HLA Antibody

Phenotypic Modulation of Vascular Smooth Muscle Cells

(2010) RYOZO NAGAI et al.   Annals of the New York Academy of Sciences

HLA Class I Molecules Partner with Integrin  4 to Stimulate Endothelial Cell Proliferation and Migration

(2010) X. Zhang et al.   Science Signaling

HLA Class I Antibodies Provoke Graft Arteriosclerosis in Human Arteries Transplanted into SCID/Beige Mice

(2009) S. Galvani et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Chediak-Higashi syndrome

(2009) Jerry Kaplan et al.   CURRENT OPINION IN HEMATOLOGY

Human leukocyte antigen antibodies in chronic transplant vasculopathy—mechanisms and pathways

(2009) Fang Li et al.   CURRENT OPINION IN IMMUNOLOGY

Cardiac Allograft Vasculopathy

(2008) Daniel Schmauss et al.   CIRCULATION

The Changing Face of Heart Transplantation

(2008) Sharon A. Hunt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Principles of bioactive lipid signalling: lessons from sphingolipids

(2008) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Immunologic targets in the etiology of allograft vasculopathy: Endothelium versus media

(2008) Maria Currie et al.   TRANSPLANT IMMUNOLOGY

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

(2007) Joseph D. Raffetto et al.   BIOCHEMICAL PHARMACOLOGY

MMPs as therapeutic targets—Still a viable option?

(2007) B FINGLETON   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY